Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on Friday for allegedly infringing three patents related to gene-editing technology used in cancer treatments.
Sign up here.
Spokespeople for Cellectis and AstraZeneca did not immediately respond to requests for comment.
“If large multinational pharmaceutical companies are allowed to illegally exploit the research and innovation of companies like Factor, it w… [1843 chars]
Source: Reuters | Published: 2025-09-26T18:35:18Z
Credit: Reuters
